Keep On Keep Up for Parkinson's
KOKU4PD
Keep On Keep Up (KOKU4PD) - Developing an App for People With Parkinson's Disease
1 other identifier
interventional
20
1 country
1
Brief Summary
The goal of this mixed methods, user research study is to evaluate the Keep On Keep Up programme for people with Parkinson's (KOKU4PD). The main aims of the study are to:
- 1.To explore the usability and acceptability of the PD specific KOKU programme from a user and health care professional perspective.
- 2.To produce a KOKU4PD digital program that is ready for National Health Service (NHS) approval and a future effectiveness evaluation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 20, 2024
CompletedFirst Posted
Study publicly available on registry
March 27, 2024
CompletedStudy Start
First participant enrolled
June 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedApril 24, 2024
April 1, 2024
9 months
March 20, 2024
April 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Usability of the KOKU app
Participants will be asked to complete questionnaires about the usability of the KOKU app and participate in an interview based on their responses to the questionnaires.
After 4 weeks of using KOKU at home
Secondary Outcomes (11)
Executive clock drawing task (CLOX 1, 2) (mean Change from baseline)
After 4 weeks of using KOKU at home
Trail Making Test (mean Change from baseline)
After 4 weeks of using KOKU at home
Freezing of Gait Questionnaire (mean Change from baseline)
After 4 weeks of using KOKU at home
Falls Efficacy scale (mean Change from baseline)
After 4 weeks of using KOKU at home
Parkinson's disease quality of life questionnaire - PDQ-39 (mean Change from baseline)
After 4 weeks of using KOKU at home
- +6 more secondary outcomes
Study Arms (1)
KOKU user
EXPERIMENTALSIngle arm study - all participants will use the KOKU app for 4 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of Parkinson's by a movement disorder specialist according to United Kingdom (UK) brain bank criteria (H\&Y stage I-III)
- Able to walk and stand without support or assistance from another person
- \>40 years
- Stable medication for the previous 1 month and anticipated over a period of 6 months.
- Adequate vision and hearing - to watch and use an iPad or Tablet.Aim: To define the study population/sample
You may not qualify if:
- Dementia (\<21 on Montreal Cognitive Assessment (MoCA) or as diagnosed according to the Movement Disorder Society guidelines
- Orthopaedic or cardiothoracic ailments that preclude safe walking
- Severe auditory or visual impairment,
- Diagnosis of clinical depression
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northumbria Universitylead
- University of Manchestercollaborator
- Northumbria Healthcare NHS Foundation Trustcollaborator
- Newcastle Universitycollaborator
- Reason Digitalcollaborator
Study Sites (1)
Northumbria University
Newcastle upon Tyne, Tyne & Wear, NE1 8ST, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 20, 2024
First Posted
March 27, 2024
Study Start
June 3, 2024
Primary Completion
March 1, 2025
Study Completion
June 30, 2025
Last Updated
April 24, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
IPD will only be available to members of the study team.